$15.76
-0.019-0.12%
Last update: Nov 12, 4:07 PM
Ultralife Corp
ULBINASDAQ
Ultralife rose 174.9% from $5.74 to $15.78, ahead of the S&P 500's +12.7%. Its worst day was May 8 (−15.3%), and its low came Nov 18 at $5.05.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.07 missed the $0.22 estimate on $43.4M revenue (est. $53.0M).
−8.8% · S&P 500 −0.8%
EPS of $0.12 missed the $0.27 estimate on $48.5M revenue (est. $57.0M).
Story events cover the past 12 months · Times ET
+7.6% · S&P 500 −0.2%
EPS of $-0.03 was reported on $47.4M revenue.
−15.3%, the year's worst day · S&P 500 +0.8%
EPS of $0.15 was reported on $47.9M revenue.
+19.4% · S&P 500 +0.6%
Ultralife shares rose 145.4%, while the S&P 500 rose 0.3%.
+145.4%, the year's best day, on 3M shares, the year's heaviest volume · S&P 500 +0.3%
EPS of $0.14 was reported on $48.3M revenue.
+0.2% · S&P 500 +0.3%
Where it ended: a close of $15.78 on Nov 12, 2026. Up next: Q4 2026 earnings on Mar 9, 2027.
Nothing in the past 12 months.
All ULBI analyst actionsNothing in the past 12 months.
All ULBI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ULBI and SPY from Benzinga historical bars. Not investment advice.
